← 홈

HER2+ 유방암

465개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 465개
ADCCBiologicRemeGenvedotin plus PD-1 blockade …Phase 3

RC48 (Disitamab Vedotin, Disitamab Vedotin (RC48))

HER2 + Breast Cancer · mCRPC

#mCRPC#ADC#Phase3#인기#항체약물접합체+5
임상시험 76상태 RECRUITING
ADCABiologicRocheDM1) and trastuzumab deruxt…Phase 3

ado-trastuzumab emtansine (Kadcyla, T-DM1)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 80%임상시험 76상태 RECRUITING
ADCCBiologicOHSU Knight Cancer InstitutePhase 2

Niraparib (Niraparib)

Advanced Breast Carcinoma; Advanced Malignant Solid Neoplasm · Advanced Breast Carcinoma

#AdvancedBreastCarcinoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 88%임상시험 75상태 DISCONTINUED
ADCBBiologicMerck Sharp & Dohme LLCPhase 2

Cytoxan (Cytoxan)

Multiple Myeloma, Refractory · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 95%임상시험 73상태 RECRUITING
ADCBBiologicTheRas, Inc., dPhase 2

mFOLFOX6 (mFOLFOX6)

Non-Small Cell Lung Cancer; NSCLC · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 63.64%임상시험 71상태 RECRUITING
ADCSBiologicShanghai Juncell TherapeuticsApproved

Hydroxychloroquine (Hydroxychloroquine)

Psoriasis; Atopic Dermatitis · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Approved#인기#항체약물접합체+4
효능 ORR 75%임상시험 70상태 ACTIVE
ADCBiologicMerck Sharp & Dohme LLCPhase 3

Rescue Medication (Rescue Medication)

Non Small Cell Lung Cancer · Triple Negative Breast Neoplasms

#TripleNegativeBreastNeoplasms#ADC#Phase3#인기#항체약물접합체+3
임상시험 69상태 RECRUITING
ADCBiologicUNICANCERPhase 2

Epirubicin hydrochloride (Epirubicin hydrochloride)

Breast Cancer · Breast Neoplasms

#BreastNeoplasms#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 43.3%임상시험 68상태 RECRUITING
ADCBiologicSpanish Breast Cancer Research …sPhase 2

Taxotere (Taxotere)

Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 88.1%임상시험 68상태 RECRUITING
ADCBiologicRocheDM1 via butelase-1 with ABD…Phase 2

trastuzumab (Herceptin, Ado-trastuzumab, Ado-trastuzumab (T) emtansine (T-DM1))

Salivary Gland Cancer; HER2 Gene Mutation · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 74.1%임상시험 67상태 RECRUITING
ADCBiologicRemeGenvedotin plus PD-1 blockade …Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin(RC48) Plus Tratuzumab)

HER2-positive Gastric Cancer; HER2-positive Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
임상시험 66상태 RECRUITING
ADCBiologicNovartis PharmaceuticalsPhase 2

Ribociclib (Ribociclib)

KRAS G12C Mutant Solid Tumors; Carcinoma, Non-Small Cell Lung · Breast Cancer

#BreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 66.7%임상시험 66상태 RECRUITING
ADCBiologicDaiichi SankyoDM1) and trastuzumab deruxt…Phase 3

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201)

Breast Cancer; HER2-positive Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 65.8%임상시험 66상태 RECRUITING
ADCBiologicHoffmann-La RochePhase 2

Xeloda (Xeloda)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+2
효능 ORR 30%임상시험 65상태 RECRUITING
AntibodyAkeso-drivenPhase 2

cadonilimab (cadonilimab)

Metastatic HER2 Positive Gastroesophageal Junction Cancer · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#인기#항체+5
임상시험 65상태 RECRUITING
ADCBiologicChia Tai Tianqing Pharmaceutica…Deruxtecan in Patients With…Phase 3

Taxane (Taxane)

HER2-negative Breast Cancer; Advanced Breast Cancer · HER2

#HER2#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 36%임상시험 64상태 RECRUITING
ADCBBiologicShanghai Junshi Bioscience Co.,…Phase 2

XELOX (XELOX)

Metastatic HER2 Positive Gastroesophageal Junction Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 47%임상시험 64상태 RECRUITING
ADCBiologicJiangsu Tasly Diyi Pharmaceutic…Phase 2

vinorelbine tartrate (vinorelbine tartrate)

Estrogen Receptor-negative Breast Cancer; Estrogen Receptor-positive Breast Cancer · Adult Lymphocyte Depletion Hodgkin Lymph

#AdultLymphocyteDepletionHodgkinL#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 32%임상시험 64상태 ACTIVE
ADCBiologicSuzhou Transcenta Therapeutics …DM1) leading to diabetic ke…Phase 2

Albumin-Paclitaxel (Albumin-Paclitaxel)

Non-small Cell Lung Cancer Metastatic; First-line Treatment · Breast Cancer Early Stage Breast Cancer

#BreastCancerEarlyStageBreastCanc#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 79.5%임상시험 63상태 RECRUITING
ADCBiologicSanofireleasePhase 2

Anthracycline (Anthracycline)

HER2-negative Breast Cancer; Advanced Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 95%임상시험 63상태 RECRUITING

2 / 24 페이지

← 이전다음 →